109 related articles for article (PubMed ID: 15165271)
1. Significance of atypia in conventional Papanicolaou smears and liquid-based cytology: a follow-up study.
Schledermann D; Ejersbo D; Hoelund B
Cytopathology; 2004 Jun; 15(3):148-53. PubMed ID: 15165271
[TBL] [Abstract][Full Text] [Related]
2. Improvement of diagnostic accuracy and screening conditions with liquid-based cytology.
Schledermann D; Ejersbo D; Hoelund B
Diagn Cytopathol; 2006 Nov; 34(11):780-5. PubMed ID: 17041948
[TBL] [Abstract][Full Text] [Related]
3. ThinPrep Pap Test promotes detection of glandular lesions of the endocervix.
Bai H; Sung CJ; Steinhoff MM
Diagn Cytopathol; 2000 Jul; 23(1):19-22. PubMed ID: 10907926
[TBL] [Abstract][Full Text] [Related]
4. [Applicative aspects of liquid-based cytology in cervical cancer screening].
Liverani M; De Paola F; Danesi S; Fedriga R; Dalbuoni V; Agnoletti R; Amadori AR; Mirra F; Bonoli W; Saragoni L
Pathologica; 2006 Dec; 98(6):629-34. PubMed ID: 17285839
[TBL] [Abstract][Full Text] [Related]
5. Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: a comparison.
Chacho MS; Mattie ME; Schwartz PE
Cancer; 2003 Jun; 99(3):135-40. PubMed ID: 12811853
[TBL] [Abstract][Full Text] [Related]
6. Reprocessing unsatisfactory ThinPrep Papanicolaou test specimens increases sample adequacy and detection of significant cervicovaginal lesions.
Islam S; West AM; Saboorian MH; Ashfaq R
Cancer; 2004 Apr; 102(2):67-73. PubMed ID: 15098249
[TBL] [Abstract][Full Text] [Related]
7. Comparison of conventional Papanicolaou smears and fluid-based, thin-layer cytology with colposcopic biopsy control in central Italy: a consecutive sampling study of 461 cases.
Rahimi S; Carnovale-Scalzo C; Marani C; Renzi C; Malvasi A; Votano S
Diagn Cytopathol; 2009 Jan; 37(1):1-3. PubMed ID: 18973131
[TBL] [Abstract][Full Text] [Related]
8. One hundred percent thorough quality control rescreening of liquid-based monolayers in cervicovaginal cytopathology.
Rowe LR; Marshall CJ; Bentz JS
Cancer; 2002 Dec; 96(6):325-9. PubMed ID: 12478679
[TBL] [Abstract][Full Text] [Related]
9. An audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia.
Thiryayi SA; Marshall J; Rana DN
Cytopathology; 2010 Aug; 21(4):223-8. PubMed ID: 19843139
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance.
Duncan L; Jacob S; Hubbard E
Cancer; 2008 Feb; 114(1):34-48. PubMed ID: 18186493
[TBL] [Abstract][Full Text] [Related]
11. [Two cytological methods for screening for cervical cancer].
Kirschner B; Simonsen K; Junge J
Ugeskr Laeger; 2008 May; 170(22):1933-7. PubMed ID: 18513478
[TBL] [Abstract][Full Text] [Related]
12. Causes and relevance of unsatisfactory and satisfactory but limited smears of liquid-based compared with conventional cervical cytology.
Siebers AG; Klinkhamer PJ; Vedder JE; Arbyn M; Bulten J
Arch Pathol Lab Med; 2012 Jan; 136(1):76-83. PubMed ID: 22208490
[TBL] [Abstract][Full Text] [Related]
13. [Cervix smears with mild atypia classified as Pap-class IIIA: results of a changed policy].
Doornewaard H; Woudt JM; Sie-Go DM; Kooijman CD
Ned Tijdschr Geneeskd; 1991 Sep; 135(36):1642-5. PubMed ID: 1922503
[TBL] [Abstract][Full Text] [Related]
14. Comparison of conventional Papanicolaou smear and SurePath liquid-based cytology in the Copenhagen population screening programme for cervical cancer.
Kirschner B; Simonsen K; Junge J
Cytopathology; 2006 Aug; 17(4):187-94. PubMed ID: 16879266
[TBL] [Abstract][Full Text] [Related]
15. Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test: a 5-year follow-up study of Papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria.
Thrall MJ; Pambuccian SE; Stelow EB; McKeon DM; Miller L; Savik K; Gulbahce HE
Cancer; 2008 Jun; 114(3):171-9. PubMed ID: 18454461
[TBL] [Abstract][Full Text] [Related]
16. ThinPrep detection of cervical and endometrial adenocarcinoma: a retrospective cohort study.
Schorge JO; Hossein Saboorian M; Hynan L; Ashfaq R
Cancer; 2002 Dec; 96(6):338-43. PubMed ID: 12478681
[TBL] [Abstract][Full Text] [Related]
17. Cervical Papanicolaou Smears in Hematopoietic Stem Cell Transplant Recipients: High Prevalence of Therapy-Related Atypia during the Acute Phase.
Yu SC; Huang HH; Li CC; Tang JL; Lee YH; Mao TL; Kuo KT; Lin CT; Liu JH; Ko BS; Yao M
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1367-1373. PubMed ID: 28450182
[TBL] [Abstract][Full Text] [Related]
18. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
Zhao C; Austin RM
Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
[TBL] [Abstract][Full Text] [Related]
20. PAP smear after radiation therapy for cervical carcinoma.
Rintala MA; Rantanen VT; Salmi TA; Klemi PJ; Grénman SE
Anticancer Res; 1997; 17(5B):3747-50. PubMed ID: 9427773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
